Feb. 27, 2020: U=U perception vs. reality; frequency of incorrect self-reported viral load levels; how HIV transmission cluster predicts care continuum gaps; integrase inhibitor uptake and discontinuation.
Want to Hire More Transgender and Gender Nonconforming Folks at Your Agency? These Staffers Have Some Blunt Advice
Many HIV service organizations say they’re open to hiring TGNC employees, but advocates say most have a long way to go.
Advocate D. Rashaan Gilmore explains how white-led HIV organizations in the U.S. engage in movement capture—e.g., the co-opting of Black racial justice efforts—under the guise of ending the HIV epidemic.
Many HIV service organizations need to grow and change, and that means becoming more reflective of the communities they serve, from bottom to top. Here's some advice on how to get there.
When Providers Don't Use Gender-Affirming Language, It Negatively Impacts HIV-Positive Transgender Women's Health
A new study shows that helping clinicians use gender-affirming language is important for transgender women in care. But we need more research on how HIV medications and feminizing hormones interact.
For people taking medications for HIV prevention, HIV treatment, STIs, or transgender health care, this couple -- in life and in business -- seeks to revolutionize the pharmacy experience at TIN Rx in San Francisco.
This population is under-represented in HIV data, and few prevention or treatment interventions exist to support them. A new meta-analysis hopes to paint a picture of what's needed.
"Providers need to not make assumptions about what black and brown and, more generally, trans patients of color need," one study co-author said.
June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.
Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.